Date: 23-27 September 2012Location: Royal Tulip, Rio de Janeiro, Brazil
Deadline for early bird registration: 31 May 2012
Deadline for abstracts: 15 March 2012
Welcome to Rio de Janeiro, on 23 to 27 September 2012, to attend the XVIII International Congress for Tropical Medicine and Malaria and XLVIII Congress of the Brazilian Society for Tropical Medicine and discuss the “Neglected Tropical Diseases: A new challenge for the XXI Century”, theme of the Congress.
José Rodrigues Coura, President of the Congress
Cláudio Tadeu Daniel-Ribeiro, President of the Scientific Committee
Some of the topics discussed at this conference are:
• Malaria as an international public health problem: epidemiology and control.
• Perspectives for malaria elimination in South America
• Severe vivax malaria
• Cerebral malaria
• Malaria associated with severe anemia
• Experimental models for a) testing drugs and vaccines and b) studying immunopathology
• Antigenic diversity and genetic polymorphism of Plasmodium.
• Assymptomatic Plasmodium Infection: parasitological and immunological considerations.
• Resistance of Plasmodium to anti-malarials.
• Information and other strategies for malaria prevention
• Use of insecticide impregnated bednets in Africa and South America and impact on malaria morbidity and control
• Perspectives for the development of a vaccine against malaria.
• Pregnancy and malaria
• Rapid tests and other new technologies and approaches for malaria diagnosis.
Official website: http://ictmm2012.ioc.fiocruz.br
Contact us: ictmm2012@mleventos.com.br
Comments
HLC Session
The Use of Human Subjects in Malaria Vector Surveillance and Research in the Americas
A session on the subject is scheduled for September 26, 2012, on room Ametista/Safira/Rubi as part of activities under the XVIII International Congress on Tropical Medicine and Malaria, in Rio de Janeiro, Brazil.
One of the major challenges for effective malaria vector surveillance in Latin America is that human landing catches are often not permitted, and what we hope to highlight in this session are the risks and benefits of permitting HLC. We also hope to discuss the alternatives to HLC, and how those can be best applied in the Americas. We would like to encourage you and your colleagues to come and participate in the session.
Please consider yourselves invited. If you would like further information feel free to contact Audrey Lenhart (ajl8@cdc.gov) or Oscar Mesones Lapouble (oscar.lapouble@gmail.com).